Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 8/20 | 0.39 |
| ▸ | NPY1R | P25929 | 5/20 | 0.39 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | NPY2R | P49146 | 4/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.36 |
| ▸ | OTC | P00480 | 1/20 | 0.35 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.34 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.34 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | RRM1 | P23921 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25300066 | 1.00 | NPY4R (0.39) | NPY4RNPY1RDPP7ALOX15NPY2R | |
| SCHEMBL5970619 | 1.00 | NPY4R (0.39) | NPY4RNPY1RDPP7ALOX15NPY2R | |
| Hydrochloric Acid SCHEMBL4422483 | 0.98 | NPY4R (0.38) | NPY4RNPY1RDPP7ALOX15NPY2R | |
| SCHEMBL4443243 | 0.98 | NPY4R (0.38) | NPY4RNPY1RDPP7ALOX15NPY2R | |
| SCHEMBL8911027 | 0.98 | NPY4R (0.38) | NPY4RNPY1RDPP7ALOX15NPY2R | |
| SCHEMBL9237239 | 0.90 | NPY4R (0.39) | NPY4RNPY1RDPP7ALOX15NPY2R | |
| SCHEMBL288133 | 0.90 | NPY4R (0.39) | NPY4RNPY1RDPP7ALOX15NPY2R | |
| SCHEMBL28712062 | 0.90 | NPY4R (0.39) | NPY4RNPY1RDPP7ALOX15NPY2R | |
| SCHEMBL16194087 | 0.89 | NPY4R (0.38) | NPY4RNPY1RDPP7ALOX15NPY2R | |
| Hydrochloric Acid SCHEMBL8039440 | 0.89 | NPY4R (0.38) | NPY4RNPY1RDPP7ALOX15NPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 919 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3930666-B1 | ORAL CARE PRODUCT | COLGATE PALMOLIVE CO (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4731755-A2 | COMPOSITIONS AND METHODS FOR REDUCING HOST CELL PROTEINS IN RECOMBINANT ADENO-ASSOCIATED VIRUS PREPARATIONS | Ultragenyx Pharmaceutical Inc. (US) | 2026-04-29 | — | — | EP | claimed |
| US-12599669-B2 | Use of low molecular weight polyvinylpyrrolidone (PVP) to reduce viscosity of high concentration protein formulations | AMGEN INC. (US) | 2026-04-14 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| EP-4634201-A1 | ARGININE WASH IN PROTEIN PURIFICATION | H. Lundbeck A/S (DK) | 2025-10-22 | — | — | EP | claimed |
| EP-4588932-A2 | PREPARATION OF FACTOR XA DERIVATIVES | ALEXION PHARMACEUTICALS, INC. (US) | 2025-07-23 | — | — | EP | claimed |
| US-20250213449-A1 | Oral Care Product And Methods Of Use And Manufacture Thereof | COLGATE-PALMOLIVE COMPANY (US) | 2025-07-03 | — | — | US | claimed |
| EP-4565608-A2 | PHARMACEUTICAL COMPOSITIONS OF FUSION PROTEINS AND METHODS OF USE THEREOF | Alexion Pharmaceuticals, Inc. (US) | 2025-06-11 | — | — | EP | claimed |
| CN-120022522-A | Drug-loaded microneedle, drug-loaded microneedle patch and electrically-controlled drug release microneedle system | 成都邦迈医创科技有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-116425860-B | Preparation of factor XA derivatives | 阿雷克森制药公司 | 2025-03-04 | — | — | CN | claimed |
| US-20040176321-A1 | Compositions of benzoquinolizine carboxylic acid antibiotic drugs | WOCKHARDT LIMITED | 2004-09-09 | — | — | US | claimed |
| WO-2004058303-A2 | COMPOSITIONS OF BENZOQUINOLIZINE CARBOXYLIC ACID ANTIBIOTIC DRUGS | WOCKHARDT LIMITED (IN) | 2004-07-15 | — | — | WO | claimed |
| CN-1465341-A | Arginine acetate oral preparation and clinical application thereof | 王兰周 | 2004-01-07 | — | — | CN | claimed |
| US-5686416-A | BRADYKININ ANALOGUES; NONA-, DECA- AND POLYPEPTIDES | ALKERMES, INC. (US) | 1997-11-11 | — | — | US | claimed |
| US-5350766-A | Method for the prevention and/or palliation of the complications of diabetes using N-alpha orginine acetyl | NEW YORK MEDICAL COLLEGE (US) | 1994-09-27 | — | — | US | claimed |
| EP-0189941-B1 | ANTIBIOTIC COMPOSITIONS | Bristol-Myers Squibb Company (US) | 1990-09-26 | — | — | EP | claimed |
| US-4876688-A | CONTAINING A CHIRAL CARBON | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECETARY OF THE DEPARTMENT OF ENERGY (US) | 1989-10-24 | — | — | US | claimed |
| EP-0140027-B1 | AQUEOUS SOLUTION FOR COOLING COLD-ROLLED STEEL STRIP IN A CONTINUOUS ANNEALING PROCESS | NIPPON STEEL CORPORATION (JP) | 1989-07-05 | — | — | EP | claimed |
| EP-0189941-A2 | Antibiotic compositions | Bristol-Myers Squibb Company (US) | 1986-08-06 | — | — | EP | claimed |
| US-4561911-A | CONTAINING AMINO ACID | NIPPON STEEL CORPORATION (JP) | 1985-12-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | CD4, TAP1, MCTS1 | NPY4R 3868/4885NPY1R 2318/4885DPP7 1167/4885 |
| US-20040176321-A1 | Compositions of benzoquinolizine carboxylic acid antibiotic drugs | H1-5, DDC, HRH1 | NPY4R 504/4885NPY1R 245/4885DPP7 264/4885 |
| US-12599669-B2 | Use of low molecular weight polyvinylpyrrolidone (PVP) to reduce viscosity of high concentration protein formulations | PNISR, ALB, ACP1 | NPY4R 808/4885NPY1R 951/4885DPP7 3279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.